2017
DOI: 10.1039/c6md00585c
|View full text |Cite
|
Sign up to set email alerts
|

A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics

Abstract: Cell wall biosynthesis inhibitors (CBIs) have historically been one of the most effective classes of antibiotics. They are the most extensively used class of antibiotics and their importance is exemplified by the β-lactams and glycopeptide antibiotics. However, this class of antibiotics has not received impunity from resistance development. In the wake of this predicament, this review presents the progress of CBIs, especially glycopeptide derivatives as antibiotics to confront antibacterial resistance. The var… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
112
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 144 publications
(121 citation statements)
references
References 130 publications
(172 reference statements)
0
112
0
2
Order By: Relevance
“…Table S1). These antibiotics included fosfomycin (FOS; 2.5 mg/ml), which inhibits MurA, the catalyst in the first step of cell wall synthesis; tunicamycin (TUN; 2.5 μg/ml), which inhibits MraY and TagO, which are respectively involved in lipid II and wall teichoic acid (WTA) synthesis 86,87 ; and ampicillin (AMP; 1 mg/ml) and vancomycin (VAN; 5 μg/ml), which inhibit the last incorporation step of cell wall precursor into the existing cell wall 88 . The lateral mobility of the FloA and FloT assemblies was monitored during the inhibition of cell wall synthesis using time-lapse fluorescence microscopy every 300 ms over 9 s. Treatment with any of these antibiotics at concentrations that inhibited cell wall synthesis reduced the diffusion coefficients of FloA and FloT (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Table S1). These antibiotics included fosfomycin (FOS; 2.5 mg/ml), which inhibits MurA, the catalyst in the first step of cell wall synthesis; tunicamycin (TUN; 2.5 μg/ml), which inhibits MraY and TagO, which are respectively involved in lipid II and wall teichoic acid (WTA) synthesis 86,87 ; and ampicillin (AMP; 1 mg/ml) and vancomycin (VAN; 5 μg/ml), which inhibit the last incorporation step of cell wall precursor into the existing cell wall 88 . The lateral mobility of the FloA and FloT assemblies was monitored during the inhibition of cell wall synthesis using time-lapse fluorescence microscopy every 300 ms over 9 s. Treatment with any of these antibiotics at concentrations that inhibited cell wall synthesis reduced the diffusion coefficients of FloA and FloT (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, MC02 T also does not possess an α-galactosidase gene to hydrolyse melibiose [54]. In contrast to some of the other Massilia strains, MC02 T showed resistance against the two antibiotics vancomycin and rifamycin SV, which inhibit bacterial cell wall biosynthesis and the DNA-dependent RNA polymerase, respectively [55,56].…”
Section: Physiological and Metabolic Characteristicsmentioning
confidence: 99%
“…Ideally, candidate drugs should target unexploited, vulnerable essential proteins in order to be incorporated into first‐ and second‐line treatments. Several classes of antibiotics inhibit steps in cell‐wall biosynthesis, and therefore, novel enzyme targets crucial to these processes make for good drug targets …”
Section: Introductionmentioning
confidence: 99%
“…Several classes of antibiotics inhibit steps in cell-wall biosynthesis, and therefore, novel enzyme targets crucial to these processes make for good drug targets. 2 Two such enzymes that play integral roles in Mtb's cell wall biosynthesis are the PPTases AcpS and PptT. 3 PPTases catalyze the attachment of the phosphopantetheine arm of coenzyme A (CoA) onto client carrier proteins associated with synthases and synthetases, activating them from inactive apo to active holo form.…”
mentioning
confidence: 99%